These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6831289)

  • 1. Potential neurotoxicity of local anaesthetic agents.
    Covino BG
    Can Anaesth Soc J; 1983 Mar; 30(2):111-6. PubMed ID: 6831289
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chloroprocaine injection.
    Reisner LS; Hochman BN; Plumer MH
    Anesth Analg; 1980 Jun; 59(6):452-4. PubMed ID: 7189987
    [No Abstract]   [Full Text] [Related]  

  • 3. Intrathecal chloroprocaine--not yet "safe" by US FDA parameters.
    Pollock JE
    Int Anesthesiol Clin; 2012; 50(1):93-100. PubMed ID: 22227425
    [No Abstract]   [Full Text] [Related]  

  • 4. Chloroprocaine neurotoxicity: four additional cases.
    Moore DC; Spierdijk J; vanKleef JD; Coleman RL; Love GF
    Anesth Analg; 1982 Feb; 61(2):155-9. PubMed ID: 7198876
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurotoxicity of spinal procaine--a caution.
    Johnson ME
    Reg Anesth Pain Med; 2001; 26(3):288. PubMed ID: 11359235
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged sensory/motor deficits following inadvertent spinal anesthesia.
    Covino BG; Marx GF; Finster M; Zsigmond EK
    Anesth Analg; 1980 Jun; 59(6):399-400. PubMed ID: 7189974
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurologic deficits following epidural or spinal anesthesia.
    Kane RE
    Anesth Analg; 1981 Mar; 60(3):150-61. PubMed ID: 7011100
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged neural blockade following regional analgesia with 2-chloroprocaine.
    Ravindran RS; Bond VK; Tasch MD; Gupta CD; Luerssen TG
    Anesth Analg; 1980 Jun; 59(6):447-51. PubMed ID: 7189986
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of bladder volumes when using neuraxial anesthesia.
    Mulroy MF; Alley EA
    Int Anesthesiol Clin; 2012; 50(1):101-10. PubMed ID: 22227426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic neurological deficits and Nesacaine-CE--an effect of the anesthetic, 2-chloroprocaine, or the antioxidant, sodium bisulfite?
    Wang BC; Hillman DE; Spielholz NI; Turndorf H
    Anesth Analg; 1984 Apr; 63(4):445-7. PubMed ID: 6703372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroprocaine not absolved of neurotoxicity.
    Moore DC
    Anesth Analg; 1984 May; 63(5):544-6. PubMed ID: 6711853
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurological toxicity of the subarachnoid infusion of bupivacaine, lignocaine or 2-chloroprocaine in the rat.
    Li DF; Bahar M; Cole G; Rosen M
    Br J Anaesth; 1985 Apr; 57(4):424-9. PubMed ID: 3986072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procaine spinal neurotoxicity.
    Johnson ME; Swanson JW
    Anesthesiology; 2008 Aug; 109(2):349-51. PubMed ID: 18648243
    [No Abstract]   [Full Text] [Related]  

  • 14. Chloroprocaine spinal anesthesia: back to the future?
    Drasner K
    Anesth Analg; 2005 Feb; 100(2):549-552. PubMed ID: 15673892
    [No Abstract]   [Full Text] [Related]  

  • 15. Limiting transient radicular irritation.
    Lambert DH
    Reg Anesth Pain Med; 2001; 26(2):177-8. PubMed ID: 11251145
    [No Abstract]   [Full Text] [Related]  

  • 16. Massive spinal block with hemicranial palsy after "test dose" for extradural analgesia.
    Kim YI; Mazza NM; Marx GF
    Anesthesiology; 1975 Sep; 43(3):370-2. PubMed ID: 1163840
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oxybuprocaine drops and eyedrops should not be given to patientson prescription].
    Cruysberg JR
    Ned Tijdschr Geneeskd; 1990 Sep; 134(39):1910. PubMed ID: 2215773
    [No Abstract]   [Full Text] [Related]  

  • 18. Santayana's prophecy fulfilled.
    Winnie AP; Nader AM
    Reg Anesth Pain Med; 2001; 26(6):558-64. PubMed ID: 11707796
    [No Abstract]   [Full Text] [Related]  

  • 19. [Particularly rapid appearance of a severe toxic keratopathy caused by oxybuprocaine].
    Jallet G; Cleirens S; Girard E; Béchetoille A
    Bull Soc Ophtalmol Fr; 1980; 80(4-5):385-7. PubMed ID: 7460172
    [No Abstract]   [Full Text] [Related]  

  • 20. Transient cardiovascular toxicity with unintentional intravascular injection of 3% 2-chloroprocaine in a 2-month-old infant.
    Cladis FP; Litman RS
    Anesthesiology; 2004 Jan; 100(1):181-3. PubMed ID: 14695742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.